Allergy - Cytology - Endocrinology - Haematology - Microbiology - Pathology - Serology - London, St. Helens & Dublin Services

  HOME

 

       Guide to Endocrinology

 1. THE ROLE OF CLINICAL PATHOLOGY
 2. DIAGNOSTIC CYTOLOGY SERVICE
  3. GUIDE TO BLOOD SAMPLING VENIPUNCTURE
 4. A GUIDE TO URINE SAMPLING
 5. A GUIDE TO SKIN SCRAPES AND OTHER DERMATOLOGICAL SAMPLING 
 6. MICROBIOLOGICAL SAMPLING 
7. A GUIDE TO FAECES SAMPLING
8. ANTICOAGULANTS & THEIR APPLICATION FOR BLOOD SAMPLING  
9. BIOCHEMICAL PROFILES AND INDIVIDUAL BIOCHEMICAL PARAMETERS
10. GUIDE TO ENDOCRINOLOGY
Canine Hypothyroidism
Canine Hyperadrenocorticism

Hyperthyroidism

Diabetes Mellitus

Hypoadrenocorticism

Summary of Endocrine Protocols for Quick Reference
[
ADRENAL & THYROID FUNCTION]
Miscellaneous Endocrine Protocols

Reproductive Endocrinology
11. FARM ANIMAL PROFILES
12. A GUIDE TO SEROLOGICAL TESTING  
13. TOXICOLOGY  
14. APPENDIX 1-7 
15. AXIOM'S - REFERENCE RANGES 

pdf.file version
SARSTEDT TUBES | CLINICAL SWABS | AXIOM COOL BOX ] 
 ALL IRELAND SERVICE
 ALLERGY TESTING
 BSAVA CPD MEETINGS
 CASE STUDIES
 COMPANY INFORMATION
 CONTACT THE LAB
 ECVCP TRAINING
 ENDOCRINE FACT SHEETS
 HAEMATOLOGY IMAGES
  ISO 9001 STATEMENT
LABORATORY GUIDE
 LONDON LABORATORY
 MICRO/CYTO/HAEM IMAGES
 NEWS LETTERS
 PACKING INSTRUCTION [P650]
 PET OWNERS LEAFLETS
 PRESS RELEASE
 PRICE LIST (details only)
 SITE MAP
 ST. HELENS LABORATORY
 USEFUL VET LINKS
 VACANCIES @ AXIOM
 VET NURSE TRAINING
 OUR LOCATION
 WHO'S WHO @ AXIOM

CANINE HYPOTHYROIDISM 

Signalment
Hypothyroidism is common endocrine disease of dogs that can affect both males and females of nearly any age although it is rare in dogs less than two years old.

Pathophysiology
Hypothyroidism is invariably primary (i.e. disease of the thyroid gland itself) and is usually caused by either lymphocytic thyroiditis or idiopathic atrophy. As the disease progresses the ability of the thyroid gland to secrete the principal thyroid hormone T4
decreases and clinical signs develop. T4 normally inhibits the secretion of cTSH from the pituitary gland by a negative feedback mechanism. In primary hypothyroidism this feedback is lost and cTSH concentrations increase.

 

CLINICAL SIGNS  
The most common clinical features of hypothyroidism include: 
 * Lethargy
 * Weight gain
 * Dermatological signs including hair loss, pyoderma, scaling & scurfing
 * Neurological signs e.g. facial nerve neuropathy
 * Exercise intolerance and weakness

Diagnostic Tests
Combined measurement of total T4 and cTSH concentrations (standard profile) provide an inexpensive and accurate method of confirming or excluding hypothyroidism. Further improvement in diagnostic accuracy is obtained by concurrent estimation of free T4 measured by dialysis (premium profile). Free T4 is the metabolically active portion of T4 and most accurately reflects tissue thyroid status. Note that the old analogue method for free T4 measurement is now known to offer no advantage over total T4 measurement. If free T4 measurement is being offered, always enquire as to whether a dialysis method is being used. Recent research has demonstrated that the presence of circulating thyroglobulin autoantibodies is very strong evidence for the presence of thyroid pathology. The comprehensive profile includes these antibodies in the test panel and therefore provides maximal information regarding thyroidal status. Dynamic tests of thyroid function are also available. If you are considering performing one of these tests, we recommend that you contact the laboratory to discuss this in advance.

Monitoring Tests
Most dogs can be well controlled with once daily thyroid hormone supplementation. Twice daily therapy is rarely required. When monitoring therapy, the time of sampling relative to thyroid hormone administration has a profound influence on the hormone concentrations that are obtained. It is therefore recommended that samples collected for monitoring profiles should be collected six hours post-pill, for total T4 and cTSH estimation. Monitoring profiles can be performed within approximately 7-14 days of starting treatment or changing the dosage. Well treated dogs usually have peak total T4 values approximately 50-70 nmol/L and cTSH concentration near the assay limit of detection (0.01-0.03 nglml).

Sample Requirements  


*
Standard profile (T4, cTSH)  1-2 ml serum (clotted)
 * Premium profile (T4, cTSH, fT4d)  1-2 ml serum (clotted)
 * Comprehensive profile (T4, cTSH, fT4d, TgAb)  1-2 ml serum (clotted)
 * Monitoring profile (T4, cTSH) (6 hours post-pill)  1-2 ml serum (clotted)

Points to Note:
Various therapies will influence thyroid test results. Ideally dogs should not have received these for a minimum of six weeks prior to sampling. If testing cannot be delayed, please ensure that the relevant drug therapies are noted on the submission form as these drugs will alter the results obtained. The most important drugs to try and avoid are:

 * Steroids
 * Anticonvulsants
 * Sulphonamides
 * Thyroid hormone replacement (unless monitoring treatment of course !)

 back to top of the page

CANINE HYPERADRENOCORTICISM 

Signalment
Hyperadrenocorticism (HAC) usually occurs in middle aged or old dogs. Predisposed breeds include poodles, small terriers (e.g. Border and Yorkshire terriers) and daschunds. Both males and females can be affected.

Pathophysiology
HAC results from excess production of glucocorticoids by the adrenal cortices. This is usually caused by excessive ACTH secretion from the pituitary gland pituitary dependant hyperadrenocorticism (PDH). PDH is most commonly caused by an adenoma the pars intermedia of the pituitary gland and accounts for approximately 80 % of all cases of HAC. The remaining 20 % of HAC cases result from excessive glucocorticoid secretion by a functioning adrenal tumour (AT) (either an adenoma or a carcinoma, both of which occur with approximately equal frequency).

 

CLINICAL SIGNS
The most common clinical features of HAC include: 
 * Polyuria
 * Polydipsia
 * Weight loss
 * Abdominal enlargement 
 * Calcinosis cutis 
 * Poor exercise tolerance 
 * “Endocrine” alopecia 
 * Polyphagia 
 * Muscle weakness 
 * Skin thinning 
 * Panting and restlessness 
 * Neurological signs referable to a pituitary mass 

Diagnostic Tests
It is important to recognise that there is no “perfect” test for HAC. Consequently, it is particularly important that tests of adrenal status are interpreted with a strong bearing ultimately being placed on your own clinical judgement. For this reason please provide as much clinical information as possible when submitting samples for the confirmation of HAC.

In the dexamethasone suppression test, cortisol is estimated before and after exogenous dexamethasone administration. In healthy dogs, the dexamethasone has a negative feedback effect on the pituitary gland and inhibits ACTH secretion. This reduces endogenous cortisol production by the adrenal cortices and consequently post dexamethasone cortisol concentrations are suppressed. However, in dogs with PDH, the pituitary gland is secreting large quantities of ACTH autonomously and is not responsive to the negative feedback effect of dexamethasone. Similarly, in dogs with AT, the secretion of cortisol by the neoplastic adrenocortical cells is independent of ACTH. Thus, in dogs with HAC caused by either PDH or AT, the cortisol concentration does not decrease significantly after dexamethasone administration. The dexamethasone suppression test is a good screening test for HAC, but can give false positive results. The most reliable method of minimising these false positive results, is to (as far as possible) avoid stressing patients during the test, and to judiciously select patients to test based on their clinical signs, routine biochemical and haematological changes, and the prior exclusion of other possible diseases.

In the ACTH stimulation test blood samples are collected for cortisol estimation before and after exogenous ACTH administration. The dose of ACTH given is supraphysiological and consequently the cortisol response to ACTH is essentially dependant upon the number of functioning adrenocortical cells. The test can therefore be considered to be an assessment of “adrenal size”. Since there is an increase in adrenal tissue in both PDH (which causes bilateral adrenal hyperplasia) and AT, an exaggerated cortisol response to ACTH usually occurs in dogs with HAC irrespective of the cause. Post-ACTH cortisol values greater than 600 nmol/L support a clinical diagnosis of HAC. The ACTH stimulation test can give false negative results and so don’t completely rule out the possibility of HAC because of a normal ACTH stimulation test, if you remain strongly clinically suspicious of the disease.

Monitoring Tests
When monitoring therapy for HAC, the ACTH stimulation test is the test of choice. A well controlled dog should have pre and post-ACTH cortisol concentrations in the region of 50 nmol/L.

The determination of the Urinary Cortisol to Creatinine Ratio (UCCR) can be used as a screening test for HAC. The UCCR is unable to definitively confirm HAC since non-adrenal disease can also give positive results, but the test can quite confidently rule out HAC as a possible diagnosis, helping in the overall final patient assessment. Since the secretion of cortisol (even in dogs with HAC) tends to be quite episodic, the estimation of “average” blood cortisol secretion would be a useful marker of adrenal status. Since cortisol is excreted in the urine, this can be achieved by measurement of urine cortisol concentration. Compensation for variable rates of glomerular filtration is achieved by determination of the UCCR. A UCCR less than 10 rules out the possibility of HAC. A UCCR more than 70 is consistent with HAC and warrants more specific testing such as the dexamethasone suppression or ACTH stimulation tests.

Differentiating PDH from AT
Endogenous ACTH measurement can be used to differentiate PDH (in which the ACTH concentration is usually elevated) from AT (in which the ACTH concentration is usually depressed). Samples must be collected using a strict protocol outlined below.

Sample Requirements
In the ACTH stimulation test clotted blood samples are collected for cortisol estimation immediately before and one hour after intramuscular administration of 250 pg soluble exogenous ACTH. In the dexamethasone suppression test clotted blood samples are collected for cortisol estimation immediately before, and three and eight hours after the intravenous administration of 0.015 mg/kg dexamethasone. For both tests 1 ml serum is required per sample. For the urinary cortisol:creatinine ratio, an overnight urine sample should be collected at approximately gam at home.

In cats the ACTH should be given intravenously. Basal samples together with samples at 60 minutes and 90 or 120 minutes should be collected. This is not a reliable test in the cat and the HDDST is recommended. 0.1mg/kg dexamethasone is given i/v and samples collected at time 0 4 and 8 hrs.

Endogenous ACTH is very labile and consequently strict sample handling procedures must be followed. Collect blood into a chilled plastic (not glass) tube containing EDTA as the anticoagulant. Gently mix and then immediately centrifuge for 3-5 minutes. Immediately decant the plasma into a chilled plain plastic (not glass) tube and freeze. Transport the sample frozen on ice for ACTH estimation.

Points to Note:
Try and avoid patient stress as much as possible during these tests. In particular, do not collect urine for the UCCR in a hospital environment as the stress of hospitalisation can in itself lead to false positive results. Instead, have the sample collected from the dog by the owner in the home environment.

Steroid therapy will interfere with both normal adrenal physiology and assays for cortisol estimation. If in doubt about which test to use in this situation, please contact the laboratory for specific advice.

 back to top of the page

HYPERTHYROIDISM 

Signalment
Hyperthyroidism is a very common disease of older cats. It is rare in cats less than seven years. All breeds and types of cats may be affected but Siamese are under?represented. Hyperthyroidism has been increasingly recognised in dogs over the past five years, but it remains a rare disease in this species.

Pathophysiology Feline hyperthyroidism almost always results from excessive secretion of T4 caused by benign adenomatous hyperplasia usually affecting both thyroid lobes. Canine hyperthyroidism is usually caused by a functional thyroid carcinoma. 

CLINICAL SIGNS
The most common clinical features associated with hyperthyroidism are: 
 * Weight loss
 * Polyphagia
 * Polyuria
 * Polydipsia
 * Tachycardia
 * Vomiting
 * Cardiorespiratory disease
 * Poor coat condition
 * Hyperactivity

Diagnostic Tests
Confirmation of hyperthyroidism is usually achieved by measurement of total T4 in a serum sample. In equivocal cases, with borderline total T4 values, dynamic tests such as the T3 suppression test can be used. However, the recommended approach in such cases is usually to wait and re-test total T4 about four weeks later. This usually clarifies thyroid status.

Monitoring Tests
Monitoring therapy for hyperthyroidism relies upon demonstration of a normalisation of thyroid hormone concentrations. It is generally desirable to decrease total T4 values to approximately 15-30 nmol/L to maintain optimal clinical control. latrogenic hypothyroidism very rarely occurs as a complication of therapy, and certainly it is much more common for cats to be inadequately treated than to be over-treated.

Sample Requirements
Serum (clotted blood) is required for total T4 estimation and this is the test of choice for both confirming the diagnosis, and monitoring therapy.

DIABETES MELLITUS 

Signalment
There are multiple underlying factors that may contribute to the development of diabetes mellitus (DM) in dogs and cats. Consequently, nearly any age or breed may be affected. However, DM occurs most commonly in middle aged dogs, and crossbreeds, cairn terriers, English setters, poodles and rottweilers have been reported to be over-represented.

Pathophysiology
The causes and contributors to a state of DM are numerous and a detailed review is beyond the scope of this manual. As a generalisation, the most common causes of DM produce a relative or absolute deficiency of insulin through combinations of reduced insulin production and/or decreased peripheral insulin sensitivity. Common specific causes include autoimmune pancreatic islet cell destruction, increased concentrations of endogenous or exogenous glucocorticoids, and increased circulating progesterone and growth hormone concentrations associated with metoestrus.
 

CLINICAL SIGNS 
The most common clinical signs of DM include: 
 * Polyuria
 * Polydipsia
 * Polyphagia
 * Recurring infections
 * Exercise intolerance
 * Cataracts
 * Weight Loss

Diagnostic Tests
Demonstration of concurrent glucosuria and persistent fasting hyperglycaemia is confirmatory of DM. Transient hyperglycaemia caused by stress and other illnesses can complicate the diagnosis of DM, particularly in cats. Broadly speaking demonstration of a fasting blood glucose concentration greater than 14 nmol/L (dogs) or 20 nmol/L (cats) is highly suspicious of DM, but if confirmation of glycaemic control is required, fructosamine estimation can be performed. Fructosamine is a glycated protein the concentration of which reflects the “average” blood glucose concentration over the previous 2-3 weeks. Markedly increased fructosamine concentrations are confirmatory of DM.

Monitoring Tests
If monitoring is being performed with blood glucose estimation, blood samples should be collected six hours after insulin jadministration to determine the nadir (lowest) blood glucose concentration. However, monitoring therapy of diabetic patients can be complicated, particularly in cats in which stress hyperglycaemia makes routine blood glucose measurement problematic. The clinical assessment of diabetic stability is therefore of paramount importance. In addition to blood and urine glucose measurement, routine estimation of blood fructosamine concentration can be used to improve evaluation of glycaemic control.
A decrease in fructosamine values towards normal is generally consistent with an improvement in glycaemic control, whilst an increase suggests a worsening of diabetic control.

Sample Requirments
Blood glucose can be performed on whole blood collected into fluoride anticoagulant tubes. Fructosamine measurement can be performed on a heparinised blood sample.

Points to Note:
Note that falsely decreased urine glucose results can be obtained if standard dip-stick methods for glucose estimation are used in patients receiving vitamin C supplements.
Blood glucose cannot be measured on heparinised or EDTA samples sent through the post. If blood is taken into these tubes by mistake, immediately centrifuge the samples and separate the plasma before sending off for analysis. Wait 2-3 weeks after instituting or changing therapy before evaluating control with fructosamine measurements.

 back to top of the page

HYPOADRENOCORTICISM  

Signalment
Hypoadrenocorticism occurs in most large breed dogs, but a particular predisposition has been reported in bearded collies, spaniels and standard poodles. It is most commonly a disease of young animals, typically aged around 3-4 years. However, it has been reported in dogs as young as three months and as old as 14 years.

Pathophysiology
The normal adrenal cortex consists of three layers, the zona glomerulosa, zona fasiculata, and zona reticularis. The first of these secretes mainly mineralocoricoids, the most important of which is aldosterone, whilst the latter two layers synthesise and secrete mainly glucocorticoids, the most important of which is cortisol. Spontaneous hypoadrenocorticism is usually caused by immune mediated destruction of the adrenal cortex. This usually affects all three cortical zones and consequently there is failure of both glucocorticoid and mineralocorticoid secretion. Failure to synthesis mineralocorticoids and glucocorticoids can have profound, frequently fatal consequences, reducing the ability to maintain electrolyte homeostasis and respond to stressful stimuli.

Clirllcal Signs
Because the adrenal cortices are destroyed progressively over a period of months or years, the clinical signs of hypoadrenocorticism can be vague and often intermittent. However, dogs can also present acutely in an “Addisonian crisis”.

THE MOST COMMON CLINICAL FEATURES OF HYPOADRENOCORTICISM INCLUDE:  
Chronic Presentation  
 * Waxing and waning history 
 * Vomiting
 * Diarrhoea
 * Polydipsia
 * Intermittent anorexia
 * Lethargy
 * Weaknes

Acute Presentation 
 * Collapse 
 * Hypovolaemia
 * Vomiting
 * Diarrhoea
 * Bradycardia
 * Hypothermia

Diagnostic Tests
The identification of hyperkalaemia and hyponatraemia is useful in supporting a diagnosis of hypoadrenocorticism. These are routinely measured on heparinised samples. Other routine abnormalities that may be encountered in dogs with Addisons disease include hypercalcaemia, mild normochromic normocytic non-regenerative anaemia, lymphocytosis and eosinophilia. Particularly in dogs with an acute crisis, increased urea and creatinine are common due to profound hypovolaemic pre-renal azotaemia. Confirmation of hypoadrenocorticism is readily achieved with an ACTH stimulation test. Failure of cortisol to significantly increase confirms a lack of functioning adrenocortical cells and supports a diagnosis of hypoadrenocorticism.

Monitoring Tests
Biochemical therapeutic monitoring of hypoadrenocorticism relies largely on electrolyte (Na & K) estimation.

Sample Requirements
Heparinised blood is suitable for the routine electrolytes. Note that separation of the plasma prior to sending to the laboratory is recommended to help accurately determine electrolyte concentrations. For the ACTH stimulation test, whole blood (clotted) should be collected immediately before and one hour after the intramuscular administration of 250 pg synthetic ACTH.

Points to Note:
Most steroids used in veterinary practice cross?react with cortisol assays and if administered prior to or during an ACTH stimulation test, will give inaccurate cortisol results. Dexamethasone does not cross react in this way and can be used in the emergency situation for patients who needs urgent glucocorticoid replacement whilst the ACTH stimulation test is being performed.

 back to top of the page

Summary of Endocrine Protocols for Quick Reference 

ADRENAL FUNCTION  
Test   Uses   Protocol 
 ACTH stimulation test
 (dogs and cats)
 Confirming spontaneous  HAC Collect fasted clotted blood sample (0 hour). Confirming iatrogenic HAC Administer 250  mg synthetic ACTH intramuscularly.  Confirming hypoadrenocorticism Collect  second whole blood sample one hour later
Monitoring therapy for HAC In cats administer 125 mg ACTH intramuscularly and collect samples  at 0.1 and 2 hours.
 Dexamethasone  suppression test
 (dogs and cats)
 Confirming spontaneous  HAC Collect fasted clotted blood sample (0 hour)
Administer 0.015 mg/kg dexamethasone
intravenously. Collect clotted blood 3 and 8 hours after dexamethasone. In cats  administer 0.1 mg/kg dexamethasone and  collect samples at 0.4 and 8hours.
 Urinary cortisol :  creatinine ratio
 (dogs &  horses)
 Screening test for  spontaneous HAC Collect morning urine sample from patient in normal home environment.
 Endogenous ACTH  estimation (dogs)  Differentiating PHD from AT Collecting blood sample into a chilled plastic (not glass) tube containing EDTA.
Spin  sample, decant into PLAIN plastic
(not  glass) and freeze plasma immediately. Transport plasma samples frozen on ice in plain tubes.
 Dexamethasone  suppression test
 (day 1) ( horses)
  Confirming HAC Collecting whole blood at approximately 5pm. Administer 40 ug/ml dexamethasone intra muscularly. Collect second whole blood sample 19 hours later (approximately 11am,
day 2).
 TRH response test  (horses)  Confirming HAC Collect clotted blood sample (perform test  in the morning). Administer 1 mg TRH intravenously (slowly over approximately  one minute). Collect whole blood samples at  0, 30 and 60  minutes.
 Combined ACTH  stimulation  /dexamethasone  suppression test (cats)  Screening test for HAC Collect blood sample then administer 0.1  mg/kg dexamethasone. Collect second  clotted sample after two hours and  immediately administer 125 mg ACTH i.v.  Collect clotted blood sample one hour later

 back to top of the page

THYROID FUNCTION
Test  Uses  Protocol 
Standard/monitoring   profile
 
(dogs: TT4 &  cTSH)
Confirming canine  hypothyroidism Monitoring  canine hypothyroidism Collect clotted blood sample
For monitoring canine thyroid hormone
therapy.
 (cats: TT4) Confirming or monitoring  hyperthyroidism Collect sample six hours post-pill
 Premium profile
 (TT4 cTSH & fT4d)
 Confirming canine  hypothyroidism Collect clotted blood sample
 Comprehensive profile  (TT4 cTSH fT4d & TgAb)  Confirming canine  hypothyroidism Collect clotted blood sample
 TSH stimulation test  (dogs)  Confirming hypothyroidism Collect clotted blood sample (0 hours) Administer 0.1 iu bovine TSH intravenously
Collect second whole blood sample six  hours later (note this product is NOT  licensed for this use).
 TRH stimulation test 1
 (dogs)
 Evaluating pituitary function Collect clotted blood sample (0 minutes)
Administer 10 mg/kg TRH  intravenously. Collect clotted blood at 20 &  30 minutes post TRH
 TRH stimulation test 2
 
(dogs)
  Ruling out hypothyroidism Collect whole blood sample (0 hours)
Administer 200 mg TRH  intravenously. Collect whole blood sample  four hours later
 TSH stimulation
 (horses)
 Evaluating thyroid function Collect clotted blood sample (0 hours)
Administer 5 i.u. TSH  intramuscularly.
Collect second clotted  sample six hours  later
 T3 suppression test
 
(cats)
 Diagnosis of equivocal  hyperthyroidism. (note this  test is not routinely  recommended) Collect clotted blood sample
Administer 20 mg T3 TID for seven doses
Collect whole blood three hours after last  T3
dose

 back to top of the page

Miscellaneous Endocrine Protocols 
Test  Uses  Protocol 
Fructosamine &  Glucose Used in diabetic patients to monitor the adequacy of therapy. Collect blood 6 hours post-insulin administration for the glucose (fluoride) and fructosamine (heparin)
estimation.
 Insulin Diagnosis of insulinoma (dogs) or HAC (horses). Collect clotted blood and immediately centrifuge and separate the serum from the red cells.
Freeze the serum and transport chilled/on ice.
 Parathyroid function Evaluation of hypercalcaemia Evaluation of hypocalcaemia Collect clotted blood and immediately centrifuge and separate the serum from the red cells. Freeze the serum and transport frozen on ice.
 HAC Hyperadrenocorticism  TSH   Thyrotropin (thyroid stimulating hormone)
 PDH Pituitary dependant hyperadrenocorticism   cTSH  Canine thyrotropin
 AT Hyperadrenocorticism caused by an adrenal tumour  TgAb  Thyroglobulin autoantibodies
 TT4 Total thyroxine T3  Triiodothyronine
 FT4d Free thyroxine (measured by dialysis)  TRH   Thyrotropin releasing hormone

Reproductive Endocrinology 
CRYPTORCHIDISM 
This test is based on the measurement of dynamic (pre and post HCG) Testosterone. In the horse the following protocol
is advised:
 * Take basal serum or heparinised plasma samples, inject 6000 iu HCG I.V. 
 * Collect a second sample between 30 mins-2 hours post injection, noting the time taken on the post sample.
 * A modified HCG test can be used in the dog and the cat, the protocol is the same except, only 750 iu HCG is used in the dog and 500 iu HCG in cats.
 * If testicular tissue is present then a significant rise in testosterone is detected post stimulation. 
 * Single sample Oestrone sulphate tests may be used in horses over 3 years of age, but are not of any value under this age and cannot be used in donkeys. This laboratory recommends the dynamic Testosterone test in most cases. 

 back to top of the page

IDENTIFICATION OF OVARIAN REMNANTS IN THE CAT
This test is based on the measurement of dynamic (pre and post HCG) progesterone. In the cat the following protocol is advised: 
 * Take basal serum or heparinised plasma samples, inject 500 iu HCG I.V. 
 * Collect a second sample as above seven days later
 * If ovarian tissue is present then a significant rise in progesterone is detected post stimulation.

DYNAMIC TESTING FOR ADRENAL SEX HORMONE PRODUCTION  
The protocols for this are undergoing constant change. As such it is advisable to telephone the laboratory prior to any testing to discuss the current protocols. 

OVULATION DETECTION IN BITCHES 
 * This involves sequential heparinised plasma or serum samples for progesterone. 
 * As the values vary slightly between plasma and serum, it is advised that either sample is used, but not mixed, i.e., do not use a plasma sample, followed two days later by a serum sample.
 * Most bitches ovulate on day 13 of the cycle, it is recommended that basal levels are established on days 9-10, then the lab will advise on when the next sample should be taken, based on the following :­

 <6 nmol/L  NOT OVULATED
 6-10 nmol/L  OVULATED MATE WITHIN 72 HOURS
 10-20 nmol/L  OVULATED MATE WITHIN 48 HOURS
 20-32 nmol/L  OVULATED MATE WITHIN 24 HOURS
 32 nmol/L  TOO LATE

 * It is wise to note that these values are usually reported 24 hours post sampling and those 24 hours need to be taken off the above times, i.e. the above times relate to the time of sampling.
PREGNANCY TESTING  

In equine serum PMSG levels can be measured for pregnancy between days 45-90. The production of PMSG is biologically variable and it is better to sample between these dates e.g. around 60 days, rather than at either end of the range.

Oestrone sulphate will be present at approximately day 70 and in significant amounts between days 110 & 240. It is present until the end of pregnancy but values fall in the last 4-6 weeks and interpretation can be difficult in this period. The cow and pig have raised oestrone sulphate levels at certain periods through pregnancy. It is advisable to therefore contact the lab first to discuss.

Recently a test for serum Relaxin concentration has been validated for confirming pregnancy in bitches. This test is available at Axiom Veterinary Laboratories. Pregnancy can be confirmed from day 21 using this method. Single progesterone values have been used in the horse and cow, at the predicted return to oestrus dates, to indicate possible early pregnancy. They are not specific indicators of pregnancy, just indicators of luteal activity, from which assumptions are made.  

 back to top of the page


"We look forward to providing our clients with continued support and innovation in clinical pathology"

Axiom Veterinary Laboratories Ltd.
The Manor House, Brunel Road, Newton Abbot, Devon TQ12 4PB, UK.
TEL: +44 (0)1626 355655 FAX: +44 (0)1626 357750/1 E-mail:admin@axiomvetlab.co.uk
 

Copyright © 2007 Axiom Veterinary Laboratories Limited. All Rights Reserved.
Designated trademarks are the property of their respective owners.